Equities

Emo Capital Corp

NUVI:PKC

Emo Capital Corp

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (USD)0.0057
  • Today's Change0.003 / 90.00%
  • Shares traded1.61k
  • 1 Year change--
  • Beta-3.0668
Data delayed at least 15 minutes, as of Jun 25 2024 19:06 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Emo Capital Corp. is a development-stage company. The Company focuses to commence operations in health and beauty care through the utilization of the Web. The Company also offers an Android Set-top-box, which enables users to use various applications on their television. The Company operates a ME4Free business division that sells online non-prescription herbal products. The Company is focused on the manufacturing and distribution of various capsules, made from all-natural ingredients, to manage sexual health by boosting testosterone levels. The Company offers RedXL through www.me4free.net Website. The Company focuses on marketing its products through display advertising, search marketing on Websites, and e-mail marketing and services from affiliate marketers.

  • Revenue in USD (TTM)--
  • Net income in USD--
  • Incorporated2006
  • Employees0.00
  • Location
    Emo Capital Corp10409 Pacific Palisades AveLAS VEGAS 89144United StatesUSA
  • Phone+1 (702) 628-7279
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Meso Numismatics Inc2.44m-10.10m437.29k1.00------0.1792-0.8113-0.81130.1959-1.900.438--33.37---181.33-192.08----69.9760.24-413.98-821.49---0.1106----57.49116.97-76.03--149.35--
Endonovo Therapeutics Inc255.72k-4.40m524.09k0.00------2.05-0.0652-0.06520.0003-0.0720.2256-------388.54-303.26----96.2174.38-1,722.26-5,956.27---1.38----85.15---495.02------
Hanyuan Biotech International Inc10.65m3.14m539.39k--0.02940.00640.14810.05060.22460.22460.76111.03----------------68.54--29.51--13.3625.660.00--50.51--106.71------
Emo Capital Corp-100.00bn-100.00bn544.35k0.00---------------0.0017-----------7,495.00-------------------------138.44------
Pharmagreen Biotech Inc1.56k-500.66k597.28k0.00------382.87-0.0011-0.00110.00-0.00450.0094--3.35---302.10-472.20----11.54---32,096.15--0.0194-71.71--------80.68------
Limitless X Holdings Inc14.21m-8.40m597.62k12.00------0.0421-2.10-2.103.58-3.513.731.7714.401,184,068.00-220.35------77.76---59.15--0.0173-9.02-----65.83---60.80------
Molecular Pharmacology (USA) Ltd0.00-105.18k599.73k0.00---------0.0009-0.00090.00-0.01880.00-------976.60-1,219.29------------------------44.29------
Health Advance Inc-100.00bn-100.00bn613.63k3.00--0.156----------0.0212----------------------------0.0356--100.00---21.75------
Evofem Biosciences Inc16.01m47.49m620.60k37.000.001--0.0130.0388-5.92-5.920.0826-1.360.9351.722.73432,756.80295.02-211.64----63.65--315.54-1,031.550.0757-2.91----8.20--164.08---10.59--
Scisparc Ltd0.00-6.96m636.32k3.00--26.12-----1.22-1.510.000.03440.00----0.00-92.51-69.39-152.41-111.07-------527.17----0.9371--113.73---97.61------
Capstone Therapeutics Corp0.00-358.00k646.20k2.00---------6.58-38.120.00-60.700.00-------113.46141.94-199.60173.06-----------2.92--------52.46------
CNS Pharmaceuticals Inc0.00-17.46m673.19k3.00---------179.17-179.170.00-20.760.00----0.00-384.86-132.47---185.75---------------------23.42------
International Stem Cell Corp7.83m-327.00k680.37k29.00------0.0869-0.0409-0.04090.97850.00451.462.5311.87270,069.00-5.81-29.22-68.13-73.8258.5859.49-3.97-21.010.4672-6.060.9898---4.78-6.8260.42---34.45--
Data as of Jun 25 2024. Currency figures normalised to Emo Capital Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.